Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BECTON DICKINSON & CO Director's Dealing 2024

Nov 29, 2024

30003_dirs_2024-11-29_4cc44d6c-c0fd-4c48-8aed-62d6b77b4301.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2024-11-26

Reporting Person: Garrison Michael David (EVP & President, Medical)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-11-26 Common Stock A 2553 $0.0 Acquired 7934 Direct
2024-11-26 Common Stock A 2275 $0.0 Acquired 10209 Direct
2024-11-26 Common Stock F 1230 $0.0 Disposed 8979 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-11-26 Stock Appreciation Rights $224.25 A 10004 Acquired 2034-11-26 Common Stock (10004) Direct

Footnotes

F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2: Represents shares received upon vesting of performance based equity award.

F3: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units as previously reported on Table I.

F4: The stock appreciation rights vest in four annual installments beginning November 26, 2025.